Jing Xiong
Southern Medical University
13 Papers
1 Citations
Jing Xiong is an academic researcher from Southern Medical University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 6, co-authored 10 publications.
Chat about Author
Papers
Effects of Interleukin-4 or Interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitis
TL;DR: The data suggest that intraperitoneal injection of IL-4 or IL-10 plasmid was a potential strategy in control of TNBS-induced murine colitis, but their combination had less effect.
HOXD9 promote epithelial-mesenchymal transition and metastasis in colorectal carcinoma.
Mengwei Liu,Yizhi Xiao,Weimei Tang,Jiaying Li,Linjie Hong,Weiyu Dai,Wenjing Zhang,Ying Peng,Xiaosheng Wu,Jing Wang,Yaying Chen,Yang Bai,Jianjiao Lin,Qiong Yang,Qiong Yang,Yusi Wang,Zhizhao Lin,Side Liu,Jing Xiong,Jide Wang,Li Xiang +20 more
TL;DR: HoxD9, a Hox family member, is involved in cancer growth and metastasis, but, its regulation mechanism at the molecular level particularly in colorectal cancer (CRC), is mostly unknown.
41
The miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop modulates the metastasis and invasion of gastric cancer cells
Weimei Tang,M Pei,Jiaying Li,Nanzhu Xu,Wushuang Xiao,Zhen Yu,Jieming Zhang,Linjie Hong,Zheng-Jun Guo,Jianjiao Lin,Weiyu Dai,Yizhi Xiao,Xiaosheng Wu,Guangnan Liu,Fachao Zhi,Guoxin Li,Jing Xiong,Ye Chen,Hui Zhang,Lixin Xiang,Aimin Li,Side Liu,Jide Wang +22 more
TL;DR: The miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop could be a critical regulator of GC progression and metastasis as mentioned in this paper .
Overexpression of Srcin1 contributes to the growth and metastasis of colorectal cancer.
Mengnan Zhang,Feng Ma,Ruyi Xie,Yao Wu,Meiyan Wu,Pei Zhang,Ying Peng,Jinjun Zhao,Jing Xiong,Aimin Li,Cheng Kequan,Ya-Li Zhang,Side Liu,Jide Wang,Xue-qing Chen +14 more
TL;DR: It is demonstrated that Srcin1 contributes to CRC carcinogenesis, invasion and metastasis and provides a rationale for a mechanistic approach to CRC treatment based on the development of SRCin1-targeted therapies.
iTRAQ-Based Proteomics Screen identifies LIPOCALIN-2 (LCN-2) as a potential biomarker for colonic lateral-spreading tumors
Xianfei Wang,Xianfei Wang,Aimin Li,Yubin Guo,Yadong Wang,Xinhua Zhao,Li Xiang,Zelong Han,Yue Li,Wen Xu,Kangmin Zhuang,Qun Yan,Jietao Zhong,Jing Xiong,Side Liu +14 more
TL;DR: The results suggest that LCN-2 constitutes a potential biomarker for LST disease progression and might be a novel therapeutic target in LSTs.